Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature

European Journal of Clinical Pharmacology

Volumn 53, Issue 2, 1997, Pages 105-110

  Ottervanger, J P ^a,b   Wilson, J H P ^b   Stricker, B H Ch ^a,b  

^a Netherlands Ctr Monitoring A R D   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angina pectoris; Drug induced; Myocardial infarction

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; ESTROGEN; EYE DROPS; IBOPAMINE; METOPROLOL; MOCLOBEMIDE; NEUROLEPTIC AGENT; NICOTINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PERINDOPRIL; RECOMBINANT ERYTHROPOIETIN; SUMATRIPTAN; THEOPHYLLINE; UNINDEXED DRUG; VERAPAMIL;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CLINICAL TRIAL; DRUG MONITORING; FATALITY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; REGISTRATION; SEX DIFFERENCE; THORAX PAIN;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; NETHERLANDS; NIFEDIPINE; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0030830680     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050346     Document Type: Article

References (63)

1. Rawlins MD (1988) Spontaneous reporting of adverse drug reactions I: the data, II: uses. Br J Clin Pharmacol 26: 1-11
2. Venning GR (1983) Identification of adverse reactions to new drugs. BMJ 286: 289-292
3. Stricker BHC (1989) Side effects of drugs: assessment of causality. Ned Tijdschr Geneeskd 133: 275-280
4. Fliers E, Dueren DR, van Zwieten PA (1991) A prostaglandin analogue as a probable cause of myocardial infarction in a young woman [letter]. BMJ 302: 416
5. Raymond R, Lunch J, Underwood D, Ieatherman J, Razavi M (1988) Myocardial infarction and normal coronary arteriography: a 10 year clinical and risk analysis of 74 patients. J Am Coll Cardiol 11: 471-477
6. Verheugt FWA, Cate JW ten, Sturk A, Imandt L, Verhorst PM, Eenige MJ van, Verwey W, Roos JP (1987) Tissue plasminogen activator activity and inhibition in acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 59: 1075-1079
7. Rosenblatt A, Selzer A (1977) The nature and clinical features of myocardial infarction with normal coronary arteriogram. Circulation 55: 578-581
8. McKenna Wj, Chew CYC, Oakley CM (1980) Myocardial infarction with normal coronary angiogram (possible mecha- nism of smoking risk in coronary artery disease). Br Heart J 43: 493-498
9. Psaty BN, Heckbert SR, Koepsall TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW (1995) The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 274: 620-625
10. Furberg CD, Psaty BM, Meyer JV, Nifedipine (1995) Dose-related increase in mortality in patients with coronary heart disease. Circulation 92: 1326-1331
11. Buring JE, Glynn RJ, Hennekens CH (1995) Calcium channel blockers and myocardial infarction: a hypothesis formulated but not yet tested. JAMA 274: 654-655
12. Jariwalla AG, Anderson EG (1978) Production of ischaemic cardiac pain by nifedipine. BMJ 1: 1181-1182
13. Sia STB, MacDonald PS, Triester B, Oliver LE, Horowitz JD, Goble AJ (1985) Aggravation of myocardial ischaemia by nifedipine. Med J Aust 142: 48-50
14. Millar AB (1982) Myocardial infarction during asthmatic attack induced by ingestion of propranolol. J R Soc Med 75: 661-662
15. Nanas JN, Sutton RB, Alazraki N, Tsagaris TJ (1987) Acute myocardial infarction in post infarct patient possibly through beta blocker-induced coronary artery spasm. Am Heart J 113: 388-391
16. Nelson WL, Fraunfelder FT, Sills JM, Arrowsmith JB, Kiritsky JN (1986) Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 102: 606-611
17. Chamberlain TJ (1989) Myocardial infarction after ophthalmic betaxolol. N Engl J Med 321: 1342
18. Davis JB (1988) Chest pain after captopril. BMJ 296: 214
19. Baker KM, Johns DW, Ayers CR, Carey R (1980) Ischaemic cardiovascular complications concurrent with administration of captopril. Hypertension 2: 73-74
20. Thorogood M, Cowen P, Mann J, Murphy M, Vessey M (1992) Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet 340: 1067-1068
21. Halper JP, Mann JJ (1988) Cardiovascular effects of antidepressant medications. Br J Psychiat 153 [suppl 3]: 87-98
22. Rudorfer MV, Potter WZ (1989) Antidepressants; a comparative review of the clinical pharmacology of the "newer" versus the "older" drugs. Drugs 37: 713-738
23. Coulter DM, Pillans PI (1995) Hypertension with moclobemide. Lancet 346: 1032
24. Klein LS, Simpson RJ Jr, Stern R, Hay ward JC, Foster JR (1982) Myocardial infarction following administration of sublingual ergotamine. Chest 82: 375-376
25. Snell NJ, Russel-Smith C, Coysh HL (1978) Myocardial ischaemia in migraine suffers taking ergotamine. Post Med J 54: 37-39
26. Hudgson P, Foster JB, Walton JN (1967) Methysergide and coronary-artery disease. Lancet 1: 444-445
27. Ottervanger JP, Stricker BHC (1995) Cardiovascular adverse reactions to sumatriptan: cause for concern? CNS Drugs 3: 90-98
28. George S, Vannozi R (1993) Myocardial infarction induced by migraine therapy. Ann Emerg Med 25: 718-719
29. Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC (1993) Transmural myocardial infarction with sumatriptan. Lancet 341: 861-862
30. Stricker BHC (1992) Coronary vasospasm and sumatriptan. BMJ 305: 118
31. Brown EG, Endersby CA, Smith RN, Talbot JCC (1991) The safety and tolerability of sumatriptan: an overview. Eur Neurol (1991) 31: 339-344
32. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G (1995) The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346: 923-926
33. Ottervanger JP, Van Witsen TB, Valkenburg HA, Stricker BHC (1994) Adverse reactions attributed to sumatriptan: a postmarketing study in general practice. Eur J Clin Pharm 47: 305-309
34. Kelly KM (1995) Cardiac arrest following use of sumatriptan. Neurology 45: 1211-1213
35. Walton-Shirley M, Flowers K, Whiteside JH (1995) Unstable angina pectoris associated with Imitrex therapy. Cathet Cardiovasc Diagn 34: 188
36. Santo M, Sidi Y, Pinkhas Y (1980) Acute myocardial infarction following intravenous salbutamol. S Afr Med J 80: 394
37. Shovlin CL, Tam FWK (1990) Salbutamol nebuliser and precipitation of critical cardiac ischaemia. Lancet 336: 1258
38. 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Safety 11: 259-283
39. Raggi P (1994) Therapeutic theophylline levels and adverse cardiac events. Ann Int Med 120: 891
40. Bittar G, Friedman HS, Dominguez A, Voperian V (1991) Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic blood concentration: an effect blocked by verapamil. J Pharmacol Exp Ther 257: 214-218
41. Thorogood M, Mann JI, Murphy M, Vessey M (1991) Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study. Br J Obstet Gynaecol 98: 1245-1253
42. Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R, Thorogood M (1996) Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. BMJ 312: 88-90
43. McLeod BC (1990) Myocardial infarction in a blood donor after administration of desmopressin. Lancet 336: 1137-1138
44. Cisteró C, Urías S, Guindo J, Lleonart R, Garcia-Moll M, Geli A, Bayes de Luna A (1992) Coronary artery spasm and acute myocardial infarction in naproxen-associated anaphylactic reaction. Allergy 47: 576-578
45. Weber S, Genevray B, Pasquier G, Chapsal J, Bonnin A, Degeorges M (1982) Severe coronary spasm during drug-induced immediate hypersensitivity. Lancet 2: 821
46. Ottervanger JP, Festen JM, Vries de AG, Stricker BHC (1995) Acute myocardial infarction while using the nicotine patch. Chest 107: 1765-1766
47. Hwang SL, Waldholt M (1992) Heart attacks reported in patch users still smoking. The Wall Street Journal:B1, June 19
48. Dacosta A, Guy JM, Tardy R, Gonthier R, Denis L, Lamaud M, Cerisier A, Verneyre H (1993) Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 14: 1709-1711
49. Warner Jr JG, Little WC (1994) Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med 120: 695
50. Wilde MI, Fitton A, McTavish D (1993) Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 45: 410-429
51. Bain SC, Rowe BR (1990) Myocardial infarction associated with the use of dextrofenfluramine. BMJ 301: 345
52. Roberts W, Glancy DL, DeVita V Jr (1968) Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol 22: 68
53. House KW, Simon SR, Pugh RP (1991) Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease. Clin Cardiol 15: 122-125
54. Tenet W, Missri J, Hager D (1986) Radiation-induced stenosis of the left main coronary artery. Cathet Cardiovasc Diagn 12: 169-171
55. Radwaner BA, Geringer R, Goldmann AM, Schwartz MJ, Kemp HG (1987) Left main coronary artery stenosis following mediastinal irradiation. Am J Med 82: 1017-1020
56. Labianca R, Luporini G (1991) 5-fluorouracil cardiotoxicity: the risk of rechallenge. Ann Oncol 2: 383
57. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC (1991) Cardiac disturbances during the administration of taxol. J Clin Oncol 9: 1704-1712
58. Schwarzer S, Eber B, Greinix H, Lind P (1991) Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy. Eur Heart J 12: 748-750
59. Talcott JA, Herman TS (1987) Acute ischemic vascular events and cisplatin [letter]. Ann Int Med 107: 121-122
60. Chavin SI, Siegel DM, Rocco TA Jr, Olson JP (1988) Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med 85: 245-249
61. Schimpf K, Zeltsch C, Zeltsch P (1982) Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A [letter]. Lancet 2: 1043
62. Mizon P, Goudemand J, Jude B, Marey A (1992) Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor. Ann Hematol 64: 309-311
63. Hollander JE, Hoffmann RS (1992) Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 10: 169-177